These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11362925)

  • 1. Researchers find new drugs to fight MAC.
    AIDS Alert; 1995 Nov; 10(11):138-9. PubMed ID: 11362925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43. PubMed ID: 11363096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAC management.
    PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifabutin for MAC questioned.
    Posit Aware; 1995; ():6. PubMed ID: 11362571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in prevention and treatment of MAC.
    Cheng B
    PI Perspect; 1995 Dec; (no 17):11. PubMed ID: 11363104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
    Singer J; Thorne A; Khorasheh S; Raboud JM; Wu AW; Salit I; Tsoukas CM; Lemieux C; Shafran SD
    Int J STD AIDS; 2000 Apr; 11(4):212-9. PubMed ID: 10772083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uveitis associated with rifabutin treatment. Apropos of 3 patients].
    Chevalley GF; Kaiser L; Bouchenaki N; Baglivo E; Kress O
    Klin Monbl Augenheilkd; 1995 May; 206(5):388-90. PubMed ID: 7609395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifabutin prophylaxis for Mycobacterium avium complex infection in patients with AIDS.
    Siegal FP
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S23-30; discussion S30-2. PubMed ID: 8785252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated Mycobacterium avium complex disease in patients with AIDS.
    Benson C
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):913-6. PubMed ID: 7811542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; Fitton A
    Drugs; 1994 Jun; 47(6):983-1009. PubMed ID: 7521834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress report: prophylaxis and therapy for MAC.
    Currier J
    AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hold the big MAC.
    Young A
    Notes Undergr; 1996 Apr; (no 32):6. PubMed ID: 11363450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine.
    Brown ST; Edwards FF; Bernard EM; Tong W; Armstrong D
    Antimicrob Agents Chemother; 1993 Mar; 37(3):398-402. PubMed ID: 8384809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
    Dautzenberg B
    Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials in Mycobacterium avium therapy: lessons to take home.
    Dautzenberg B
    Res Microbiol; 1994; 145(3):197-206. PubMed ID: 7809472
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.